Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer (Q67988822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

author name string

J Vibe-Petersen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

N Tvede

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

M Diamant

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

A A Kjerulff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

H R Sørensen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

V Andersen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

20 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

121-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1903673%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01742540

20 September 2019

exact match

0 references

cites work

Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin

1 reference

12 December 2020

The soluble interleukin-2 receptor in haematological disorders.

1 reference

12 December 2020

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

1 reference

12 December 2020

Suppressor cell function in solid tumor cancer patients

1 reference

12 December 2020

Expression of interleukin 2 receptors on activated human B cells

1 reference

12 December 2020

The natural five-year course in bronchial carcinoma. Epidemiologic results

1 reference

12 December 2020

Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma

1 reference

12 December 2020

Soluble CD8 during T cell activation

1 reference

12 December 2020

Serum interleukin-2 receptor: clinical and biological implications.

1 reference

12 December 2020

The interleukin 2 receptor

1 reference

12 December 2020

Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-alpha against primary lung cancer targets

1 reference

12 December 2020

Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients

1 reference

12 December 2020

Peripheral blood lymphocytes from patients with cancer lack interleukin-2 (IL-2) receptor expression: isolation of mRNA encoding IL-2R

1 reference

12 December 2020

Soluble interleukin-2 receptors in systemic lupus erythematosus

1 reference

12 December 2020

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes

1 reference

12 December 2020

High serum levels of soluble interleukin-2 receptors in sarcoidosis

1 reference

12 December 2020

Interleukin-2 in cancer therapy

1 reference

12 December 2020

Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome

1 reference

12 December 2020

Chemotherapy in adenocarcinoma of the lung.

1 reference

12 December 2020

A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac

1 reference

12 December 2020

Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes.

1 reference

12 December 2020

The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses

1 reference

12 December 2020

Serum levels of soluble interleukin 2 receptor in patients with non-haematological disorders

1 reference

12 December 2020

Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS.

1 reference

12 December 2020

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

1 reference

12 December 2020

An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro

1 reference

12 December 2020

The released interleukin 2 receptor binds interleukin 2 efficiently

1 reference

12 December 2020